|
Johnson, T R; Fischer, J E; Graham, B S (2001) Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. J Gen Virol 82:2107-16
|
|
Johnson, T R; Graham, B S (1999) Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J Virol 73:8485-95
|
|
Johnson, T R; Johnson, J E; Roberts, S R et al. (1998) Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J Virol 72:2871-80
|
|
Fischer, J E; Johnson, J E; Kuli-Zade, R K et al. (1997) Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol 71:8672-7
|
|
Tang, Y W; Graham, B S (1997) T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J Clin Invest 99:2183-91
|
|
Graham, B S (1996) Immunological determinants of disease caused by respiratory syncytial virus. Trends Microbiol 4:290-3
|
|
Tang, Y W; Graham, B S (1995) Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J Infect Dis 172:734-8
|
|
Graham, B S (1995) Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am J Respir Crit Care Med 152:S63-6
|
